TABLE 2.
A complementation assay for p53 function in Ad12-induced RNU2 fragility
| p53 expression | MOI |
RNU2 fragilitya as shown by:
|
|
|---|---|---|---|
| % of cells | % of RNU2 loci | ||
| Wild type | 10 | 32 | 23 |
| V143A | 10 | 29 | 20 |
| R175H | 10 | 22 | 16 |
| R248W | 10 | 26 | 19 |
| R273H | 10 | 28 | 21 |
| Control | 0 | 9 | 5 |
At least 100 metaphases were examined for each datum. The p53 expression vectors have been described previously (5, 35). The complementation assay with Saos-2 cells was performed as detailed in Materials and Methods. All data were normalized to transfection efficiency as judged by the β-galactosidase color assay (46). Control cells were transfected with 20 μg of the pCH110 β-galactosidase expression vector. Note that the values for percent fragility refer to total number of metaphases examined; when we assumed a 100% infection and corrected for transfection efficiency (30 to 40%), RNU2 fragility was usually observed in >70% of the cells transfected with wild-type or mutant p53.